Health­care re­ports lit­tle hir­ing dur­ing Oc­to­ber

Modern Healthcare - - LATE NEWS -

The health­care in­dus­try saw lit­tle job cre­ation in Oc­to­ber, adding about 11,600 po­si­tions, while the over­all U.S. un­em­ploy­ment rate was pegged at 9%. Health­care jobs held steady at 14.2 mil­lion with an in­crease of less than 0.1%, based on pre­lim­i­nary fig­ures from the U.S. Bureau of La­bor Sta­tis­tics. Last month, the bureau re­ported the over­all U.S. un­em­ploy­ment rate at 9.1%. Health­care added an av­er­age of 27,957 jobs a month dur­ing the 12-month pe­riod ended in Oc­to­ber, ac­cord­ing to sea­son­ally ad­justed fig­ures. Dur­ing that pe­riod, the in­dus­try added 367,500 jobs, for a 2.7% hike since Oc­to­ber 2010. Job growth at hos­pi­tals slowed to less than 1%, adding 3,300 jobs for the month to a work­force of 4.8 mil­lion. Out­pa­tient-care cen­ters saw the largest per­cent­age in­crease, ris­ing nearly 0.5% for 2,900 new jobs. Out­pa­tient care em­ploys about 630,000 peo­ple over­all. Physi­cian of­fices, which saw a large bump in Septem­ber, con­tin­ued to grow, al­beit at a rate sim­i­lar to other health­care fields. Doc­tors’ of­fices added 2,200 jobs at about a 1% clip in Oc­to­ber to a work­force of 2.4 mil­lion. was formed last year af­ter Mckesson ac­quired US On­col­ogy. Brous­sard had served as chair­man and CEO of US On­col­ogy be­fore the $2.16 bil­lion deal was an­nounced in Novem­ber. His ap­point­ment at Hu­mana is ef­fec­tive in De­cem­ber. Mccallister, Hu­mana’s chair­man and CEO, will re­tire in the next 12 to 18 months, ac­cord­ing to a news re­lease. He is 59. The Louisville, Ky.based in­surer also said it pro­moted Chief Op­er­at­ing Of­fi­cer James Murray, 57, to ex­ec­u­tive vice pres­i­dent. Mccallister, Brous­sard and Murray will join the of­fice of the chair­man, an ini­tia­tive that “Mccallister is cre­at­ing to guide the com­pany in key strate­gic ar­eas and en­sure a smooth lead­er­ship tran­si­tion,” ac­cord­ing to the Hu­mana re­lease. A spokes­woman at Mckesson Spe­cialty Health said the com­pany is con­duct­ing an in­ter­nal and ex­ter­nal search to iden­tify a suc­ces­sor for Brous­sard. stand­ing mat­ters which do not re­flect the com­pany that we are to­day,” Glax­o­smithk­line CEO An­drew Witty said in the state­ment. “In re­cent years, we have fun­da­men­tally changed our pro­ce­dures for com­pli­ance, mar­ket­ing and sell­ing in the U.S. to en­sure that we oper­ate with high stan­dards of in­tegrity and that we con­duct our busi­ness openly and trans­par­ently.” The com­pany said it de­vel­oped a new in­cen­tive com­pen­sa­tion sys­tem that awards sales rep­re­sen­ta­tives on the qual­ity of ser­vices they pro­vide to health­care pro­fes­sion­als rather than in­di­vid­ual sales tar­gets as the ba­sis for bonuses. The sum would ex­ceed the $2.3 bil­lion that Pfizer agreed to pay in 2009, which the Jus­tice Depart­ment had said was the largest-ever health­care fraud set­tle­ment.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.